|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net loss | |||||
| Share based compensation | |||||
| Depreciation and amortization | |||||
| Impairment loss | |||||
| Bad debt expense (recovery) | |||||
| Inventory write down | |||||
| Accretion expense | |||||
| Change in fair value of convertible debt | |||||
| Debt forgiveness - related party | |||||
| Gain on sale of subsidiary - related party | |||||
| Gain on sales and disposal of assets | |||||
| Trade and other receivables, net | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| Proceeds from sale of subsidiary – related party | |||||
| Payment for intangible assets – related party | |||||
| Purchase of property and equipment | |||||
| Sales of property and equipment | |||||
| Net cash used in investing activities | |||||
| Sale of ordinary shares and warrants | |||||
| Proceeds from convertible debt | |||||
| Repayments of convertible debt | |||||
| Cash Flows From Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Share based compensation | |||||
| Stock option expense (Note 2) | |||||
| Depreciation and amortization | |||||
| Impairment loss | |||||
| Bad debt recovery | |||||
| Inventory write down | |||||
| Accretion expense | |||||
| Change in fair value of convertible debt | |||||
| Gain on sale of subsidiary - related party | |||||
| (Gain) loss on sale and disposal of assets | |||||
| Non-cash lease expense | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts and other receivable, net | |||||
| Accounts receivable - related party | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued liabilities (Note 2) | |||||
| Accounts payable and accrued expense - related party | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash Flows From Investing Activities | |||||
| Proceeds from sale of subsidiary - related party | |||||
| Payment for intangible asset | |||||
| Payment for intangible asset-related party | |||||
| Purchase of property and equipment | |||||
| Proceeds from sales of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash Flows From Financing Activities | |||||
| Sale of ordinary shares, pre-funded warrants, and warrants | |||||
| Proceeds from convertible debt | |||||
| Repayments of convertible debt | |||||
| Payments on silent partnerships | |||||
| Payments on silent partnerships - related party | |||||
| Payments of lease liabilities | |||||
| Effect of changes in exchange rates | |||||
| Net change in cash | |||||
| Cash at beginning of period | |||||
| Cash at end of period | |||||
| Interest expense | |||||
| Right of use asset additions | |||||
| Acquisition of intangible asset for payable and stock payable | |||||
| Issuance of ordinary shares for cashless exercise | |||||
| Issuance of ordinary shares for conversion of debt | |||||
| Reclassification of reserve due to warrants expired | |||||
| Payments on loan payable | |||||
| Net cash provided by financing activities | |||||
| Effect of changes in exchange rates | |||||
| Net change in cash | |||||
| Cash at beginning of year | |||||
| Cash at end of year | |||||
| Supplemental cash flow information: | |||||
| Interest expense | |||||
| Non-Cash Investing and Financing Activities | |||||
| Right-of-use asset additions | |||||
| Acquisition of intangible asset for structured payments | |||||
| Issuance of ordinary shares for conversion of debt | |||||
| Payable offset by sale of asset | |||||
| Loan payable for prepaid insurance | |||||
Loading...